---
figid: PMC9588328__ECAM2022-1911311.001
pmcid: PMC9588328
image_filename: ECAM2022-1911311.001.jpg
figure_link: /pmc/articles/PMC9588328/figure/fig1/
number: Figure 1
figure_title: ''
caption: 'The antitumor effect of PFGS combined with Sor in H22 tumor-bearing mice.
  (a) PFGS combined with Sor showed significant inhibition of tumor volume (n = 6).
  (b) PFGS combined with Sor showed significant inhibition of tumor weight. Data are
  presented as the mean ± SD. ∗p < 0.05 compared with the control group; ∗∗p < 0.01
  compared with the control group; ##p < 0.01 compared with the Sor group; ++ CDI<0.7
  had a significant synergistic effect.'
article_title: Effects of Sensitized Sorafenib with a Paeoniflorin and Geniposide
  Mixture on Liver Cancer via the NF-κB-HIF-2α-SerpinB3 Pathway.
citation: Jun-Fei Li, et al. Evid Based Complement Alternat Med. 2022;2022:1911311.
year: '2022'

doi: 10.1155/2022/1911311
journal_title: 'Evidence-based Complementary and Alternative Medicine : eCAM'
journal_nlm_ta: Evid Based Complement Alternat Med
publisher_name: Hindawi

keywords:
---
